# NATCOPHARM — Natco Pharma Limited

> Natco Pharma Limited (NATCOPHARM) on the NSE: 7,572 sessions of split-adjusted history from 1995.

Canonical: https://patternsradar.com/s/NATCOPHARM

## Latest session

- Close: 882.4 INR (0.56% on the day), 2026-08-21
- Delivery: 34.89% of volume taken to demat (20-day average 46.08%)
- Volume: 3.64L shares, turnover ₹32.1Cr
- Relative volume: 0.81× of its own 20-day average

## Technicals

- RSI(14): 39.57
- ATR(14): 27.07
- SMA 50: 920.37, SMA 200: 943.55
- 52-week range: 789 – 1,226.8 (-28.07% from the high)

## Performance

- 1 week -2.3%, 1 month -3.94%, 3 months -24.56%
- 6 months 0.11%, 1 year -2.42%

## Fundamentals

- Market cap: 15,804.7 crore
- P/E (TTM): 13.81 — NULL when trailing earnings are negative or unfiled, never a misleading number
- EPS (TTM): 63.91 INR, split-adjusted to match the price series
- Revenue growth: -44.68% YoY, -0.53% QoQ
- Profit growth: -57.01% YoY, -23.23% QoQ

## Quarterly results

Last 8 filed quarters, consolidated basis, in rupees crore as filed.

| Quarter | Revenue | Total expenses | Profit before tax | Net profit | EPS | Net margin |
| --- | --- | --- | --- | --- | --- | --- |
| 2024-09-30 | 1,371.1 | 616.7 | 818.2 | 676.5 | 37.81 | 49.34% |
| 2024-12-31 | 474.8 | 487.4 | 163.7 | 132.4 | 7.43 | 27.89% |
| 2025-03-31 | 1,221 | 781.4 | 505.9 | 406 | 22.7 | 33.25% |
| 2025-06-30 | 1,328.9 | 818.7 | 571.9 | 480.3 | 26.84 | 36.14% |
| 2025-09-30 | 1,363 | 849.3 | 613.7 | 517.9 | 28.94 | 38% |
| 2025-12-31 | 647.3 | 544.3 | 161.1 | 151.3 | 8.46 | 23.37% |
| 2026-03-31 | 739.1 | 672.8 | 144.1 | 269 | 14.96 | 36.4% |
| 2026-06-30 | 735.2 | 608.8 | 185.6 | 206.5 | 11.53 | 28.09% |

A quarterly filing with NSE carries a profit and loss only. There is no balance sheet behind it, and so no debt, cash flow or return-on-capital figure in this dataset. EPS is restated onto the split-adjusted basis the price series uses; every rupee figure is exactly as filed.

## Shareholding

As filed for 2026-06-30:

- Promoter: 49.42%
- Public: 50.58%

Institutional and pledge percentages come from a filing stage whose backfill has reached about 1% of instruments, so they are absent here rather than zero.

## Recent filings

- 2026-08-14: results for 2026-06-30 both — https://nsearchives.nseindia.com/corporate/ixbrl/INTEGRATED_FILING_INDAS_187243_14082026160405_iXBRL_WEB.html
- 2026-07-09: shareholding for 2026-06-30 — https://nsearchives.nseindia.com/corporate/xbrl/SHP_1689944_09072026054425_WEB.xml
- 2026-05-29: results for 2026-03-31 both — https://nsearchives.nseindia.com/corporate/ixbrl/INTEGRATED_FILING_INDAS_163674_29052026172020_iXBRL_WEB.html
- 2026-04-09: shareholding for 2026-03-31 — https://nsearchives.nseindia.com/corporate/xbrl/SHP_1647709_09042026102912_WEB.xml
- 2026-02-18: dividend
- 2026-02-12: results for 2025-12-31 both — https://nsearchives.nseindia.com/corporate/ixbrl/INTEGRATED_FILING_INDAS_142392_12022026164856_iXBRL_WEB.html
- 2026-01-19: shareholding for 2025-12-31 — https://nsearchives.nseindia.com/corporate/xbrl/SHP_1603978_19012026020157_WEB.xml
- 2025-11-20: dividend

Dated by the day the company broadcast the filing. 152 events are indexed for this instrument.

## About the instrument

- Listed: 1995-12-27 — latest session 2026-08-21 (7,572 sessions)
- ISIN: INE987B01026
- Series: EQ
- Liquidity rank: #522 by 20-day average turnover — not index membership

Delivery figures come from NSE's daily reports and are unavailable for older sessions. Prices are end-of-day, split- and bonus-adjusted, from the eod2 dataset.

Charts and the full bar history are on the rendered page: https://patternsradar.com/s/NATCOPHARM.